SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-000875
Filing Date
2023-01-18
Accepted
2023-01-18 16:36:36
Documents
14
Period of Report
2023-01-18
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sqz-20230118.htm   iXBRL 8-K 68154
2 EX-99.1 sqz-ex99_1.htm EX-99.1 16832
3 GRAPHIC img61662729_0.jpg GRAPHIC 10824
  Complete submission text file 0000950170-23-000875.txt   230382

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sqz-20230118.xsd EX-101.SCH 2460
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sqz-20230118_lab.xml EX-101.LAB 14572
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sqz-20230118_pre.xml EX-101.PRE 10672
8 EXTRACTED XBRL INSTANCE DOCUMENT sqz-20230118_htm.xml XML 5107
Mailing Address 200 ARSENAL YARDS BLVD., STE. 210 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., STE. 210 WATERTOWN MA 02472 617-898-8824
SQZ Biotechnologies Co (Filer) CIK: 0001604477 (see all company filings)

IRS No.: 462431115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39662 | Film No.: 23534852
SIC: 2836 Biological Products, (No Diagnostic Substances)